These five cell lines were engineered to be deficient in O-linked glycosylation by knocking out key enzymes of the O-glycoslyation pathway using Crispr/Cas9. These include UDP-galactose-4- epimerase (GALE), galactokinase 1 (GALK1) and galactokinase 2 (GALK2).
Highlights:
O-linked glycosylation is the attachment of a sugar molecule to an oxygen atom in an amino acid residue in a protein. O-linked glycosylation is a form of glycosylation that occurs in the Golgi apparatus in eukaryotes. These key enzymes are critical for glycan salvage and synthesis of UDP-galactose & UDP-GalNac. These cell lines are ideal for many studies where one wishes to investigate whether O-glycans are important or play a role in their research.
From the laboratory of James M. Termini, PhD, University of Miami.
Catalog Number | Product | DataSheet | Size | AVAILABILITY | Price | Qty |
---|
Product Type: | Cell Line |
Name: |
GALE KO GALK1 KO GALK2 KO GALE+GALK1 KO GALE+GALK2 KO |
Cell Type: | CRISPR modified HEK293T cell lines |
Accession ID: | Q14376 |
Organism: | Human |
Morphology: | Adherent |
Source: | Embryonic kidney |
Biosafety Level: | BSL1 |
Subculturing: | Split 1:10 to 1:20 when cells reach 80% confluence |
Growth Conditions: | DMEM + 10% FBS + Pen/Strep |
Cryopreservation: | 90% FBS + 10% DMSO |
Storage: | LN2 |
Shipped: | Dry Ice |
If you publish research with this product, please let us know so we can cite your paper.